Mustang Bio, Inc.
MBIO
$0.59
$0.00-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.50% | -10.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.59% | 57.91% | |||
| Operating Income | -10.59% | -57.91% | |||
| Income Before Tax | -12.25% | -77.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.25% | -77.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.25% | -77.51% | |||
| EBIT | -10.59% | -57.91% | |||
| EBITDA | -10.67% | -56.64% | |||
| EPS Basic | -12.19% | -70.76% | |||
| Normalized Basic EPS | -12.18% | -70.58% | |||
| EPS Diluted | -12.19% | -70.76% | |||
| Normalized Diluted EPS | -12.18% | -70.58% | |||
| Average Basic Shares Outstanding | 0.05% | 3.99% | |||
| Average Diluted Shares Outstanding | 0.05% | 3.99% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||